Literature DB >> 8134579

Screening-detected and symptomatic ductal carcinoma in situ: mammographic features with pathologic correlation.

A J Evans1, S Pinder, I O Ellis, M Sibbering, C W Elston, D N Poller, R Wilson.   

Abstract

PURPOSE: To compare the mammographic and pathologic features of screening-detected and symptomatic ductal carcinoma in situ (DCIS).
MATERIALS AND METHODS: The mammographic and pathologic features of 54 screening-detected and 77 symptomatic cases of DCIS were compared. Patients were aged 30-76 years (mean, 58 years).
RESULTS: Diffuse involvement was seen in 10 patients (13%) with symptoms but in none of the screening-detected group (P < .05). The disease was radiologically more extensive in the symptomatic group. Calcifications in the symptomatic group (n = 48) were less likely to have a ductal distribution than those in the screening-detected group (n = 48) (30 [63%] vs 40 [83%], respectively; P < .05). At histologic examination in some cases, the symptomatic group (n = 76) included eight (11%) patients with cribriform-micropapillary, large-cell tumors (P < .05) and less comedocarcinoma (20 [26%] vs 23 [45%], respectively; P < .05) compared with the screening-detected group (n = 51).
CONCLUSION: The results show differences in the radiologic and pathologic features of screening-detected and symptomatic DCIS.

Entities:  

Mesh:

Year:  1994        PMID: 8134579     DOI: 10.1148/radiology.191.1.8134579

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  14 in total

1.  [Diagnostics of microcalcifications from minimally invasive biopsies in mammography screening: results from the prevalence phase].

Authors:  D Hungermann; S Weigel; E Korsching; W Heindel; W Böcker; T Decker
Journal:  Pathologe       Date:  2009-02       Impact factor: 1.011

2.  Breast conservation therapy for ductal carcinoma in situ (DCIS): does presentation of disease affect long-term outcomes?

Authors:  Harrison X Bai; Sabin B Motwani; Susan A Higgins; Bruce G Haffty; Lynn D Wilson; Donald R Lannin; Suzanne B Evans; Meena S Moran
Journal:  Int J Clin Oncol       Date:  2013-06-19       Impact factor: 3.402

3.  [Prognostic factors in ductal carcinoma in situ].

Authors:  A Lebeau
Journal:  Pathologe       Date:  2006-09       Impact factor: 1.011

4.  Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast.

Authors:  C C Wykoff; N Beasley; P H Watson; L Campo; S K Chia; R English; J Pastorek; W S Sly; P Ratcliffe; A L Harris
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

Review 5.  Molecular genetics of solid tumours: translating research into clinical practice. What we could do now: breast cancer.

Authors:  S R Lakhani
Journal:  Mol Pathol       Date:  2001-10

Review 6.  What is the malignant nature of human ductal carcinoma in situ?

Authors:  Virginia Espina; Lance A Liotta
Journal:  Nat Rev Cancer       Date:  2010-12-02       Impact factor: 60.716

Review 7.  Modern concepts of ductal carcinoma in situ (DCIS) and its diagnosis through percutaneous biopsy.

Authors:  Ute Kettritz
Journal:  Eur Radiol       Date:  2007-09-27       Impact factor: 5.315

8.  Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence.

Authors:  Gaiane M Rauch; Brian P Hobbs; Henry M Kuerer; Marion E Scoggins; Ana P Benveniste; Young Mi Park; Abigail S Caudle; Patricia S Fox; Benjamin D Smith; Beatriz E Adrada; Savitri Krishnamurthy; Wei T Yang
Journal:  Ann Surg Oncol       Date:  2015-09-28       Impact factor: 5.344

9.  Predictive factors for invasive cancer in surgical specimens following an initial diagnosis of ductal carcinoma in situ after stereotactic vacuum-assisted breast biopsy in microcalcification-only lesions.

Authors:  Hatice Gümüş; Philippa Mills; David Fish; Metehan Gümüş; Karina Cox; Haresh Devalia; Sue Jones; Peter Jones; Ali R Sever
Journal:  Diagn Interv Radiol       Date:  2016 Jan-Feb       Impact factor: 2.630

Review 10.  Current management of ductal carcinoma in situ.

Authors:  A Barth; R J Brenner; A E Giuliano
Journal:  West J Med       Date:  1995-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.